Market Overview In 2022, the global market size for Castrate Resistant Prostate Cancer (CRPC) was valued at USD 10.9 billion, with projections indicating growth to USD 22.5 billion by 2032, at a compound annual growth rate (CAGR) of 8.4% during the forecast period. Factors such as the increasing prevalence of prostate cancer among men, the aging population, and heightened research and...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian